Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

GRC vs SCL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GRC Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 6–4 Matrix Metrics)

GRC Overall Winner 6-Pillar Tally: GRC 3 – 3 SCL Matrix Metrics: GRC 6 – 4 SCL

As of Nov 20, 2026, The Gorman-Rupp Company Common Shares (GRC) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). GRC carries a Unified Composite Score of 42.1/100 (HOLD) at $64.03 (19.8x Forward P/E, 16.0% operating margin), whereas SCL carries 41.5/100 (SELL) at $63.48 (18.0x Forward P/E, 3.5% operating margin).

  • Technical & Structure Timing Caution: GRC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.3); meanwhile SCL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 40.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GRC vs SCL
GRC NYSE Head-to-Head Winner
The Gorman-Rupp Company Common Shares
Pumps & Pumping Equipment
$64.03
-4.66% 1D
Market Cap $1.8B
TTM Revenue $722M
Forward P/E 19.8x
Beta / 30D Vol 1.31β · 44% Vol
Unified Composite Score
42.1 / 100 HOLD
Tech 29.0 Fund 50.0 Flow 59.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 30
RSI-14: 30.3 · SMA20: $70.89 · SMA50: $72.63
SCL NYSE
Stepan Co.
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.48
-2.34% 1D
Market Cap $1.5B
TTM Revenue $2.53B
Forward P/E 18.0x
Beta / 30D Vol 0.55β · 32% Vol
Unified Composite Score
41.5 / 100 SELL
Tech 25.0 Fund 44.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 40.5 · SMA20: $67.16 · SMA50: $64.40

6-Pillar Scorecard Institutional Category Breakdown (GRC 3 – 3 SCL)

Columns: Metric · GRC · SCL
1. Valuation Multiples SCL
Forward P/E 19.8x 18.0x
Trailing P/E 24.0x N/M
PEG Ratio 1.68x 1.75x
EV / Revenue 2.7x 0.8x
2. Growth & Scale SCL
Revenue Growth (YoY) +11.8% +17.3%
Earnings Growth (YoY) +99.5% +65.5%
TTM Revenue (USD) $722M $2.53B
Market Cap $1.8B $1.5B
3. Profitability & Quality GRC
Gross Margin 32.5% 12.0%
Operating Margin 16.0% 3.5%
Net Profit Margin 10.2% 0.2%
Return on Equity (ROE) 17.0% 0.4%
4. Balance Sheet & Cash Flow GRC
Cash Generation (TTM) $110M $4.6M
Cash Flow Margin 15.3% 0.2%
Net Cash / Leverage $191M Net Debt (0.54x D/E) $578M Net Debt (0.56x D/E)
Dividend Yield 1.11% 2.39%
5. Options & Positioning SCL
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 38.5% (8th %ile) 33.5% (5th %ile)
Put/Call OI Skew 3.00x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat GRC
OpEx & R&D Intensity 16.5% of Rev ($119M) 8.5% of Rev ($215M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Specialty Industrial Machinery Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GRC (6) vs SCL (4)
Institutional Metric GRC SCL Criterion Row Edge
Market Capitalization
Scale
$1.8B $1.5B Larger Scale GRC
Trailing P/E Ratio
Valuation
24.0x N/M Lower Multiple GRC
Forward P/E Ratio
Valuation
19.8x 18.0x Lower Multiple SCL
Revenue Growth (YoY)
Growth
+11.8% +17.3% Higher Growth SCL
Operating Margin (TTM)
Profitability
16.0% 3.5% Higher Margin GRC
Net Profit Margin
Profitability
10.2% 0.2% Higher Margin GRC
Return on Equity (ROE)
Capital Efficiency
17.0% 0.4% Higher ROE GRC
52-Week Range Position
Momentum
42% ($43–$93) 70% ($42–$73) Stronger Trend SCL
Beta / 30D Volatility
Risk Regime
1.31β · 44% Vol 0.55β · 32% Vol Lower Realized Risk SCL
Unified Institutional Score
Composite Signal
42.1 / 100 (HOLD) 41.5 / 100 (SELL) Higher Composite GRC
Trailing 12M Revenue (USD)
Operating Scale
$722M $2.53B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
32.5% 12.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.68x PEG · 2.7x EV/Rev 1.75x PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$110M ($191M Net Debt (0.54x D/E)) $4.6M ($578M Net Debt (0.56x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SCL +7.39 pp
GRC: -8.7% · SCL: -1.31%
3M Horizon SCL +19.84 pp
GRC: -17.72% · SCL: +2.12%
6M Horizon SCL +33.79 pp
GRC: -11.88% · SCL: +21.91%
1Y Horizon SCL +2.97 pp
GRC: +46.82% · SCL: +49.79%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period GRC Revenue SCL Revenue GRC Op. Margin SCL Op. Margin Margin Leader
FY2018 $410M $1.99B 12.2% 7.5% GRC
FY2019 $400M $1.86B 11.0% 6.8% GRC
FY2020 $350M $1.87B 10.2% 9.2% GRC
FY2021 $380M $2.35B 10.4% 7.3% GRC
FY2022 $520M $2.77B 7.7% 7.5% GRC
FY2023 $660M $2.33B 13.2% 2.5% GRC
FY2024 $660M $2.18B 13.9% 3.2% GRC
FY2025 $680M $2.33B 14.0% 3.4% GRC

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GRC BREAKDOWN
104d in phase · OBV DISTRIBUTION
Current IV 38.5%
IV Percentile 8th %ile
Put/Call OI Skew 3.00x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact GRC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SCL CONSOLIDATION
81d in phase · OBV ACCUMULATION
Current IV 33.5%
IV Percentile 5th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SCL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GRC Moat Profile Scale & Operating Efficiency Moat
Specialty Industrial Machinery Operator
Competes within the Specialty Industrial Machinery value chain with $1.8B market capitalization and 16.0% operating margin.
OpEx & R&D Reinvestment 16.5% of Rev ($119M)
90D Engineering Disclosures 0 Published
SCL Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $1.5B market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 8.5% of Rev ($215M)
90D Engineering Disclosures 0 Published

Investor FAQ GRC vs SCL Key Questions & Quantitative Answers

As of Nov 20, 2026, The Gorman-Rupp Company Common Shares (GRC) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, R&D & Supply-Chain Moat). GRC carries a Unified Composite Score of 42.1/100 (HOLD) at $64.03 (19.8x Forward P/E, 16.0% operating margin), whereas SCL carries 41.5/100 (SELL) at $63.48 (18.0x Forward P/E, 3.5% operating margin). Technical & Structure Timing Caution: GRC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 30.3); meanwhile SCL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 40.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SCL leads the Growth & Scale pillar: GRC posts +11.8% YoY revenue growth and +99.5% YoY earnings growth on $722M TTM revenue (32.5% gross margin, 16.0% operating margin), compared with SCL at +17.3% YoY revenue growth and +65.5% YoY earnings growth on $2.53B TTM revenue (12.0% gross margin, 3.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), GRC cumulative revenue shifted +65.9% while SCL shifted +17.1%. In operating R&D and SG&A reinvestment, GRC deploys 16.5% of Rev ($119M) (0 90-day corporate R&D disclosures) versus 8.5% of Rev ($215M) (0 disclosures) for SCL.

SCL screens cheaper on headline valuation multiples. GRC trades at 19.8x Forward P/E, 24.0x Trailing P/E, 1.68x PEG, and 2.7x EV/Revenue (15.3% FCF margin), whereas SCL trades at 18.0x Forward P/E, N/M Trailing P/E, 1.75x PEG, and 0.8x EV/Revenue (0.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GRC (17.0% ROE) versus SCL (0.4% ROE) capital efficiency.

In options market volatility and institutional positioning, GRC carries 38.5% implied volatility (8th %ile, Compressed (<25th %ile)), a 3.00x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.31β · 44% Vol realized risk). By comparison, SCL carries 33.5% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.55β · 32% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.